3 Big Pharma Companies Guilty of 'Unfair and Deceptive Trade Practices'

A Massachusetts court has ruled that 3 of Americasruled that Bristol-Myers Squibb overcharged for its
largest pharmaceutical companies have engaged incancer drugs Taxol, Vepesid, Cytoxan, Blenoxane and
unfair and deceptive trade practices. reports thatRubex. She levied damages of $183,454 for one
AstraZeneca, Schering, Bristol-Myers Squib violatedgroup of plaintiffs and is collecting information to
general laws by inflating the average wholesale pricesfigure the other group's damages." Althought the
that they reported for certain drugs, includingjudge agreed that Johnson & Johnsons conduct
chemotherapies. According to Steve Berman, thewas at times troubling, apparently did not cross the
attorney who led the suit, Massachusetts ruling wasline of "egregious misconduct" and was cleared of the
a test case and trials are planned for the rest of thecharges. Berman said, "We are also grateful that she
states. This is just the tip of the iceberg of problemsfound the biggest victims were the patients who had
for AstraZeneca and Pfizer. said, "U.S. District Judgeto pay these outrageous prices out of pocket as a
Patti Saris found that AstraZeneca overcharged forresult of the defendants wrongful conduct." Visit this
Zoladex, a treatment for prostate cancer and leviedConsumer Advocacy website for information on
damages of nearly $4.5 million for one group ofordering medication from an online no prescription
plaintiffs. She said the court needed additionalpharmacy.
information to figure damages for the other. Saris